Cancer Letters
Volume 294, Issue 1 , Pages 91-100, 1 August 2010

TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway

  • Dengfeng Wang

      Affiliations

    • Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu 610041, PR China
    • Department of Physiology and Pharmacology, School of Biomedical Sciences, The University of Queensland, Brisbane, Qld 4072, Australia
  • ,
  • Jenny Nga Ting Fung

      Affiliations

    • Department of Physiology and Pharmacology, School of Biomedical Sciences, The University of Queensland, Brisbane, Qld 4072, Australia
  • ,
  • Ya Tuo

      Affiliations

    • Department of Physiology and Pharmacology, School of Biomedical Sciences, The University of Queensland, Brisbane, Qld 4072, Australia
    • Department of Forensic Sciences, College of Medicine, Xi’an Jiaotong University, Xi’an 710061, PR China
  • ,
  • Lina Hu

      Affiliations

    • Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu 610041, PR China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 28 85502391; fax: +86 28 85503776 (L. Hu), tel.: +61 07 33653856; fax: +61 07 33652398 (C. Chen).
  • ,
  • Chen Chen

      Affiliations

    • Department of Physiology and Pharmacology, School of Biomedical Sciences, The University of Queensland, Brisbane, Qld 4072, Australia
    • Corresponding Author InformationCorresponding authors. Tel.: +86 28 85502391; fax: +86 28 85503776 (L. Hu), tel.: +61 07 33653856; fax: +61 07 33652398 (C. Chen).

Received 8 December 2009; received in revised form 19 January 2010; accepted 21 January 2010. published online 02 March 2010.

Abstract 

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible immediate-early response protein 14 (Fn14) have been detected in several human tumors, and demonstrated to regulate multiple cellular responses, including proliferation, survival, migration, apoptosis and differentiation, suggesting roles in cancer. The objective of this study was to clarify the role of TWEAK/Fn14 in the development of human endometrial cancer. We found that TWEAK gene expression was down-regulated and Fn14 gene expression was up-regulated in human endometrial cancer specimens compared with that in normal endometrial specimens; TWEAK acting on Fn14 decreased cell viability by inducing apoptosis through caspase pathways in endometrial cancer cells. Our results suggest that Fn14 expression is high in endometrial cancers whereas local produced TWEAK may be low. TWEAK/Fn14 pathway activation may promote cancer cell apoptosis, which provides a new therapeutic target for human endometrial cancer treatment.

Keywords: TWEAK, Fn14, Endometrial cancer, Apoptosis, Caspase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(10)00053-4

doi:10.1016/j.canlet.2010.01.027

Cancer Letters
Volume 294, Issue 1 , Pages 91-100, 1 August 2010